O	O	O	0	10	Inhibition	Inhibition	B-NP	NN	O	0	ROOT	O
O	O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
T3	B-Entity	B-Entity	14	16	NF	NF	B-NP	NN	B-protein	6	NMOD	B-protein
T3	I-Entity	I-Entity	16	17	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T3	I-Entity	I-Entity	17	22	kappa	kappa	I-NP	NN	I-protein	6	NMOD	I-protein
T3	I-Entity	I-Entity	23	24	B	B	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	O	25	27	by	by	B-PP	IN	O	1	NMOD	O
O	O	O	28	34	sodium	sodium	B-NP	NN	O	9	NMOD	O
O	O	O	35	45	salicylate	salicylate	I-NP	NN	O	11	NMOD	O
O	O	O	46	49	and	and	I-NP	CC	O	11	NMOD	O
O	O	O	50	57	aspirin	aspirin	I-NP	NN	O	7	PMOD	O
O	O	O	58	59	[	[	O	(	O	13	VMOD	O
O	O	O	59	62	see	see	B-VP	VB	O	1	NMOD	O
O	O	O	63	71	comments	comment	B-NP	NNS	O	13	OBJ	O
O	O	O	71	72	]	]	O	)	O	13	VMOD	O

O	O	O	74	77	The	The	B-NP	DT	O	5	NMOD	O
O	O	O	78	91	transcription	transcription	I-NP	NN	B-protein	5	NMOD	B-protein
O	O	O	92	98	factor	factor	I-NP	NN	I-protein	5	NMOD	I-protein
T4	B-Entity	B-Entity	99	106	nuclear	nuclear	B-NP	JJ	I-protein	5	NMOD	I-protein
T4	I-Entity	I-Entity	107	113	factor	factor	I-NP	NN	I-protein	8	NMOD	I-protein
T4	I-Entity	I-Entity	113	114	-	-	B-NP	HYPH	O	8	NMOD	O
T4	I-Entity	I-Entity	114	119	kappa	kappa	I-NP	NN	O	8	NMOD	O
T4	I-Entity	I-Entity	120	121	B	B	I-NP	NN	O	15	SUB	O
O	O	O	122	123	(	(	O	(	O	14	DEP	O
T5	B-Entity	B-Entity	123	125	NF	NF	B-NP	NN	B-protein	13	NMOD	B-protein
T5	I-Entity	I-Entity	125	126	-	-	B-NP	HYPH	I-protein	13	NMOD	I-protein
T5	I-Entity	I-Entity	126	131	kappa	kappa	I-NP	NN	I-protein	13	NMOD	I-protein
T5	I-Entity	I-Entity	132	133	B	B	I-NP	NN	I-protein	14	DEP	I-protein
O	O	O	133	134	)	)	O	)	O	8	NMOD	O
O	O	O	135	137	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	138	146	critical	critical	B-ADJP	JJ	O	15	PRD	O
O	O	O	147	150	for	for	B-PP	IN	O	16	AMOD	O
O	O	O	151	154	the	the	B-NP	DT	O	20	NMOD	O
O	O	O	155	164	inducible	inducible	I-NP	JJ	O	20	NMOD	O
O	O	O	165	175	expression	expression	I-NP	NN	O	17	PMOD	O
O	O	O	176	178	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	179	187	multiple	multiple	B-NP	JJ	O	26	NMOD	O
O	O	O	188	196	cellular	cellular	I-NP	JJ	B-DNA	26	NMOD	B-DNA
O	O	O	197	200	and	and	I-NP	CC	I-DNA	26	NMOD	I-DNA
O	O	O	201	206	viral	viral	I-NP	JJ	I-DNA	26	NMOD	I-DNA
T6	B-Entity	B-Entity	207	212	genes	gene	I-NP	NNS	I-DNA	21	PMOD	I-DNA
O	O	O	213	221	involved	involve	B-VP	VBN	O	26	NMOD	O
O	O	O	222	224	in	in	B-PP	IN	O	27	VMOD	O
O	O	O	225	237	inflammation	inflammation	B-NP	NN	O	31	NMOD	O
O	O	O	238	241	and	and	I-NP	CC	O	31	NMOD	O
O	O	O	242	251	infection	infection	I-NP	NN	O	28	PMOD	O
O	O	O	252	261	including	include	B-PP	VBG	O	31	NMOD	O
O	O	O	262	273	interleukin	interleukin	B-NP	NN	B-protein	43	NMOD	B-protein
O	O	O	273	274	-	-	B-NP	HYPH	O	33	NMOD	O
O	O	O	274	275	1	1	I-NP	CD	O	34	NMOD	O
O	O	O	276	277	(	(	O	(	O	40	DEP	O
O	O	O	277	279	IL	IL	B-NP	NN	B-protein	38	NMOD	B-protein
O	O	O	279	280	-	-	B-NP	HYPH	I-protein	40	DEP	I-protein
O	O	O	280	281	1	1	I-NP	CD	I-protein	38	NMOD	I-protein
O	O	O	281	282	)	)	O	)	O	33	NMOD	O
O	O	O	282	283	,	,	O	,	O	43	P	O
T1	B-Protein	B-Protein	284	286	IL	IL	B-NP	NN	B-protein	43	NMOD	B-protein
T1	I-Protein	I-Protein	286	287	-	-	O	HYPH	I-protein	48	NMOD	I-protein
T1	I-Protein	I-Protein	287	288	6	6	B-NP	CD	I-protein	43	NMOD	I-protein
O	O	O	288	289	,	,	O	,	O	48	P	O
O	O	O	290	293	and	and	O	CC	O	48	NMOD	O
O	O	O	294	302	adhesion	adhesion	B-NP	NN	B-protein	48	NMOD	B-protein
O	O	O	303	312	molecules	molecule	I-NP	NNS	I-protein	32	PMOD	I-protein
O	O	O	312	313	.	.	O	.	O	15	P	O

O	O	O	314	317	The	The	B-NP	DT	O	5	NMOD	O
O	O	O	318	322	anti	anti	I-NP	AFX	O	5	NMOD	O
O	O	O	322	323	-	-	I-NP	HYPH	O	5	P	O
O	O	O	323	335	inflammatory	inflammatory	I-NP	JJ	O	5	NMOD	O
O	O	O	336	341	drugs	drug	I-NP	NNS	O	9	NMOD	O
O	O	O	342	348	sodium	sodium	I-NP	NN	O	7	NMOD	O
O	O	O	349	359	salicylate	salicylate	I-NP	NN	O	9	NMOD	O
O	O	O	360	363	and	and	I-NP	CC	O	9	NMOD	O
O	O	O	364	371	aspirin	aspirin	I-NP	NN	O	10	SUB	O
O	O	O	372	381	inhibited	inhibit	B-VP	VBD	O	0	ROOT	O
O	O	O	382	385	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	386	396	activation	activation	I-NP	NN	O	10	OBJ	O
O	O	O	397	399	of	of	B-PP	IN	O	12	NMOD	O
T7	B-Entity	B-Entity	400	402	NF	NF	B-NP	NN	B-protein	17	NMOD	B-protein
T7	I-Entity	I-Entity	402	403	-	-	B-NP	HYPH	I-protein	17	NMOD	I-protein
T7	I-Entity	I-Entity	403	408	kappa	kappa	I-NP	NN	I-protein	17	NMOD	I-protein
T7	I-Entity	I-Entity	409	410	B	B	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	O	410	411	,	,	O	,	O	17	P	O
O	O	O	412	417	which	which	B-NP	WDT	O	17	NMOD	O
O	O	O	418	425	further	further	B-ADVP	RB	O	21	VMOD	O
O	O	O	426	434	explains	explain	B-VP	VBZ	O	19	SBAR	O
O	O	O	435	438	the	the	B-NP	DT	O	23	NMOD	O
O	O	O	439	448	mechanism	mechanism	I-NP	NN	O	21	OBJ	O
O	O	O	449	451	of	of	B-PP	IN	O	23	NMOD	O
O	O	O	452	458	action	action	B-NP	NN	O	24	PMOD	O
O	O	O	459	461	of	of	B-PP	IN	O	25	NMOD	O
O	O	O	462	467	these	these	B-NP	DT	O	28	NMOD	O
O	O	O	468	473	drugs	drug	I-NP	NNS	O	26	PMOD	O
O	O	O	473	474	.	.	O	.	O	10	P	O

O	O	O	475	479	This	This	B-NP	DT	O	2	NMOD	O
O	O	O	480	490	inhibition	inhibition	I-NP	NN	O	3	SUB	O
O	O	O	491	500	prevented	prevent	B-VP	VBD	O	24	VMOD	O
O	O	O	501	504	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	505	516	degradation	degradation	I-NP	NN	O	3	OBJ	O
O	O	O	517	519	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	520	523	the	the	B-NP	DT	O	12	NMOD	O
T8	B-Entity	B-Entity	524	526	NF	NF	I-NP	NN	B-protein	12	NMOD	B-protein
T8	I-Entity	I-Entity	526	527	-	-	B-NP	HYPH	I-protein	12	NMOD	I-protein
T8	I-Entity	I-Entity	527	532	kappa	kappa	I-NP	NN	I-protein	12	NMOD	I-protein
T8	I-Entity	I-Entity	533	534	B	B	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	O	535	544	inhibitor	inhibitor	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	O	544	545	,	,	O	,	O	16	P	O
O	O	O	546	547	I	I	B-NP	NN	B-protein	16	NMOD	B-protein
O	O	O	548	553	kappa	kappa	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	O	554	555	B	B	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	O	555	556	,	,	O	,	O	24	P	O
O	O	O	557	560	and	and	O	CC	O	24	VMOD	O
O	O	O	561	570	therefore	therefore	B-ADVP	RB	O	24	VMOD	O
T9	B-Entity	B-Entity	571	573	NF	NF	B-NP	NN	B-protein	23	NMOD	B-protein
T9	I-Entity	I-Entity	573	574	-	-	B-NP	HYPH	I-protein	23	NMOD	I-protein
T9	I-Entity	I-Entity	574	579	kappa	kappa	I-NP	NN	I-protein	23	NMOD	I-protein
T9	I-Entity	I-Entity	580	581	B	B	I-NP	NN	I-protein	24	SUB	I-protein
O	O	O	582	585	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	586	594	retained	retain	I-VP	VBN	O	24	VC	O
O	O	O	595	597	in	in	B-PP	IN	O	25	VMOD	O
O	O	O	598	601	the	the	B-NP	DT	O	28	NMOD	O
O	O	O	602	609	cytosol	cytosol	I-NP	NN	O	26	PMOD	O
O	O	O	609	610	.	.	O	.	O	24	P	O

O	O	O	611	617	Sodium	Sodium	B-NP	NN	O	2	NMOD	O
O	O	O	618	628	salicylate	salicylate	I-NP	NN	O	4	NMOD	O
O	O	O	629	632	and	and	O	CC	O	4	NMOD	O
O	O	O	633	640	aspirin	aspirin	B-NP	NN	O	6	SUB	O
O	O	O	641	645	also	also	B-ADVP	RB	O	6	VMOD	O
O	O	O	646	655	inhibited	inhibit	B-VP	VBD	O	0	ROOT	O
O	O	O	656	658	NF	NF	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	O	658	659	-	-	O	HYPH	I-protein	10	NMOD	I-protein
O	O	O	659	664	kappa	kappa	B-NP	NN	I-protein	10	NMOD	I-protein
O	O	O	665	666	B	B	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	O	666	667	-	-	B-NP	HYPH	O	13	P	O
O	O	O	667	676	dependent	dependent	I-NP	JJ	O	13	NMOD	O
O	O	O	677	690	transcription	transcription	I-NP	NN	O	29	NMOD	O
O	O	O	691	695	from	from	B-PP	IN	O	13	NMOD	O
O	O	O	696	699	the	the	B-NP	DT	O	18	NMOD	O
T2	B-Protein	B-Protein	700	702	Ig	Ig	I-NP	NN	B-DNA	18	NMOD	B-DNA
T2	I-Protein	I-Protein	703	708	kappa	kappa	I-NP	NN	I-DNA	18	NMOD	I-DNA
T10	B-Entity	B-Entity	709	717	enhancer	enhancer	I-NP	NN	I-DNA	14	PMOD	I-DNA
O	O	O	718	721	and	and	O	CC	O	29	NMOD	O
O	O	O	722	725	the	the	B-NP	DT	O	29	NMOD	O
T11	B-Entity	B-Entity	726	731	human	human	I-NP	JJ	B-DNA	29	NMOD	B-DNA
T11	I-Entity	I-Entity	732	748	immunodeficiency	immunodeficiency	I-NP	NN	I-DNA	29	NMOD	I-DNA
T11	I-Entity	I-Entity	749	754	virus	virus	I-NP	NN	I-DNA	29	NMOD	I-DNA
T11	I-Entity	I-Entity	755	756	(	(	O	(	I-DNA	29	NMOD	I-DNA
T11	I-Entity	I-Entity	756	759	HIV	HIV	B-NP	NN	I-DNA	29	NMOD	I-DNA
T11	I-Entity	I-Entity	759	760	)	)	O	)	I-DNA	29	NMOD	I-DNA
T11	I-Entity	I-Entity	761	765	long	long	B-NP	JJ	I-DNA	29	NMOD	I-DNA
T11	I-Entity	I-Entity	766	774	terminal	terminal	I-NP	JJ	I-DNA	29	NMOD	I-DNA
T11	I-Entity	I-Entity	775	781	repeat	repeat	I-NP	NN	I-DNA	6	OBJ	I-DNA
O	O	O	782	783	(	(	O	(	O	32	DEP	O
T12	B-Entity	B-Entity	783	786	LTR	LTR	B-NP	NN	B-DNA	32	DEP	B-DNA
O	O	O	786	787	)	)	O	)	O	29	NMOD	O
O	O	O	788	790	in	in	B-PP	IN	O	29	NMOD	O
O	O	O	791	802	transfected	transfecte	B-NP	VBN	B-cell_line	36	NMOD	B-cell_line
O	O	O	803	804	T	T	I-NP	NN	I-cell_line	36	NMOD	I-cell_line
O	O	O	805	810	cells	cell	I-NP	NNS	I-cell_line	33	PMOD	I-cell_line
O	O	O	810	811	.	.	O	.	O	6	P	O
